Insulin resistance and hyperinsulinemia ultimately lead to elevated plasma insulin concentration, which may stimulate tumor growth by inducing the mitogenic effect and increasing bioavailable insulin-like growth factor 1 (Kazer, 1995; Chappell et al., 2001). The gene discussed is INS; the disease is neoplasm.